A new concept: treating corneal amblyopia with corneal wavefront guided LASIK

Article

Cases of amblyopia should undergo corneal wavefront analysis and would benefit from corneal wavefront-linked LASIK.

Cases of amblyopia should undergo corneal wavefront analysis and would benefit from corneal wavefront-linked LASIK, according to Cyres and Keiki Mehta from the Mehta International Eye Institute and Supervision Laser Center, Mumbai, India.

Over a period of one year, 60 cases of unilateral anisometropic amblyopia (age range seven to 25 years) were tested on the keratron scout topo-corneal wavefront analyser. The uncorrected and best corrected visual acuity (UCVA, BCVA) and total RMS were recorded.

LASIK was performed using a 200 Hz flying spot laser with a pupil-based tracker using a proprietary corneal wavefront-linking software (ORK-CAM; Schwind). Flaps were created using the Cariazzo-Pendular microkeratome with a 110 micron head.

Of the 60 eyes, nine improved by one line of BCVA, 47 improved by two lines and two eyes each improved by three and four lines. RMS corneal aberration decreased from between 40% to 56% and those subjects who recorded a greater reduction in RMS were also the subjects who gained more lines of BCVA.

In view of their results, the researchers concluded that all cases of amblyopia will benefit from corneal wavefront linked LASIK.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.